|
AD000091.2
|
Uncharacterized
|
563.4
|
2.83E–07
|
0.001188912
|
|
C11orf95
|
Chromosome 11 open reading frame 95. Diseases associated with C11orf95 include ependymoma and chondroid lipoma.
|
100.9
|
5.80E–07
|
0.001188912
|
|
LPAR1
|
Lysophosphatidic acid receptor 1. Its related pathways are PI3K-Akt signaling pathway and Ras signaling pathway.
|
20
|
6.66E–07
|
0.001188912
|
|
LBR
|
Lamin B receptor. Its related pathways are Metabolism and Metabolism.
|
20.6
|
2.85E–06
|
0.003815476
|
|
GNAI1
|
Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1. Its related pathways are GPCR Pathway and GPCR Pathway.
|
7.6
|
9.21E–06
|
0.008563212
|
|
HOXD13
|
Homeobox D13. This gene is related to sequence-specific DNA binding transcription factor activity and chromatin binding.
|
231.4
|
9.61E–06
|
0.008563212
|
|
EARS2
|
Glutamyl-tRNA synthetase 2, mitochondrial. Its related pathways are Metabolism and Gene Expression.
|
22.6
|
1.17E–05
|
0.008563212
|
|
PRDM13
|
PR domain containing 13. This gene related to methyltransferase activity.
|
30.4
|
1.28E–05
|
0.008563212
|
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I). Its related pathways are Endocytosis and Delta508-CFTR traffic/ER-to-Golgi in CF.
|
23
|
2.52E–05
|
0.013834245
|
|
CTC-504A5.1
|
Affiliated with the ncRNA class
|
16.6
|
2.58E–05
|
0.013834245
|
|
CHST10
|
Carbohydrate sulfotransferase 10. Its related pathways are Other types of O-glycan biosynthesis and Biological oxidations.
|
8.9
|
4.28E–05
|
0.019890845
|
|
PRPSAP1
|
Phosphoribosyl pyrophosphate synthetase-associated protein 1. This gene is related to magnesium ion binding and enzyme inhibitor activity.
|
10
|
4.46E–05
|
0.019890845
|
|
TLX3
|
T-cell leukemia homeobox 3. Its related pathways are Transcriptional misregulation in cancer and SIDS Susceptibility Pathways.
|
103.6
|
5.11E–05
|
0.021040208
|
|
RP11-259G18.1
|
Uncharacterized
|
21.7
|
7.50E–05
|
0.024582733
|
|
DAZ4
|
Deleted in azoospermia 1. This gene is related to this gene include RNA binding and nucleotide binding.
|
7
|
7.68E–05
|
0.024582733
|
|
TMEM52
|
Transmembrane protein 52
|
50.8
|
7.68E–05
|
0.024582733
|
|
AC007879.2
|
Uncharacterized
|
13.3
|
7.93E–05
|
0.024582733
|
|
PCMTD2
|
Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2. This gene is related to protein-L-isoaspartate (D-aspartate) O-methyltransferase activity.
|
10.4
|
8.26E–05
|
0.024582733
|
|
HNF1A-AS1
|
HNF1A antisense RNA 1 affiliated with the antisense RNA class.
|
13.6
|
8.86E–05
|
0.024984166
|
|
SUV420H2_1
|
Uncharacterized
|
21.7
|
9.76E–05
|
0.026140534
|
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13 kDa, V1 subunit G2. A multisubunit enzyme that mediates acidification of intracellular compartments of eukaryotic cells.
|
27.3
|
1.06E–04
|
0.027114541
|
|
TCP10L
|
T-complex 10-like. An important paralog of this gene is TCP10L2.
|
13.9
|
1.23E–04
|
0.028632706
|
|
MCU
|
Mitochondrial calcium uniporter. It is related to calcium channel activity and uniporter activity.
|
7.8
|
1.23E–04
|
0.028632706
|
|
ZFHX3
|
Zinc finger homeobox 3. Its related pathways are Transcriptional Regulatory Network in Embryonic Stem Cell.
|
8
|
1.59E–04
|
0.035570625
|
|
RP11-508 M8.1
|
Uncharacterized
|
10.7
|
1.85E–04
|
0.039536736
|
|
CCL3
|
Chemokine (C-C motif) ligand 3. Its related pathways are Signaling by GPCR and TGF-Beta Pathway.
|
31
|
2.13E–04
|
0.043901777
|
|
LL22NC03-63E9.3
|
Uncharacterized LOC648691, affiliated with the ncRNA class.
|
−22.2
|
2.30E–04
|
0.045120747
|
|
RP11-180P8.3
|
Uncharacterized
|
46.1
|
2.36E–04
|
0.045120747
|
|
RP11-213H15.3
|
Uncharacterized
|
11.1
|
2.56E–04
|
0.046011494
|
|
IL17D
|
Interleukin 17D. Its related pathways are IL-17 Family Signaling Pathways and IL-17 Family Signaling Pathways.
|
40
|
2.58E–04
|
0.046011494
|
|
AC016831.7
|
Uncharacterized
|
5.8
|
2.71E–04
|
0.04688832
|
|
NFKBIL1
|
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
8
|
2.98E–04
|
0.049193252
|
|
SLC2A6
|
Solute carrier family 2, member 6. Its related pathways are PAK Pathway and HIF1Alpha Pathway.
|
7.9
|
3.03E–04
|
0.049193252
|
